Cancer

August 17, 2017

Kidney cancer patient, survivor event set for Sept. 9

Vanderbilt-Ingram Cancer Center (VICC) will sponsor an educational conference for kidney cancer patients, survivors and family members Saturday, Sept. 9, 8 a.m. – 2 p.m., in the Preston Research Building, Suite 898.

By VUMC News and Communications
August 9, 2017

Breast Cancer Genomic Profiling Reveals Clues to Treatment Resistance

Thanks to advances in treatment, the relative five-year survival rate from all combined subtypes of breast cancer now exceeds 90 percent and yet the disease remains the third leading cause of cancer deaths in the United States after lung and colorectal cancers.

By Bill Snyder
August 9, 2017

Stress may switch on bone “mets”

New findings could explain the link between chronic stress and reduced survival in women diagnosed with breast cancer, and could lead to new strategies to improve treatment outcomes.

By Bill Snyder
x-ray of stomach
August 8, 2017

Early drivers of gastric cancer

Using bioinformatics approaches, Vanderbilt investigators have identified gene expression networks that are deregulated in mouse and human stomach cancers.

By Leigh MacMillan
August 3, 2017

Children’s Hospital patient, doctor bond through music

When 17-year-old Ray Cruz was invited to perform at the Ryman Auditorium, he agreed to do it under one condition — that his doctor perform alongside him.

By VUMC News and Communications
red three darts arrows in the target center
August 3, 2017

Investigators match novel cancer mutations with potential therapies

Research led by Vanderbilt-Ingram Cancer Center (VICC) investigators may have solved a mystery about why a targeted therapy stops working in a small group of breast cancer patients.

By VUMC News and Communications
August 3, 2017

HDAC3 role in B-cell development

The histone deacetylase HDAC3 is required for the maturation of B cells, white blood cells that produce antibodies.
By Leigh MacMillan
July 20, 2017

Drivers of breast cancer metastasis

Signaling through a complex of proteins called mTORC2 plays a role in breast cancer migration, invasion and metastasis, Vanderbilt researchers reported.
By Leigh MacMillan
July 13, 2017

Arteaga to direct UT Southwestern cancer center

Carlos L. Arteaga, M.D., director of the Center for Cancer Targeted Therapies (C2T2), director of the Breast Cancer Research Program and associate director for Clinical Research at Vanderbilt-Ingram Cancer Center (VICC), has been named director of the Harold C. Simmons Comprehensive Cancer Center and associate dean of Oncology Programs at the UT Southwestern Medical Center in Dallas.
By VUMC News and Communications
July 5, 2017

Bile acids, microbiota and colon cancer

Bile acids produced by a western diet alter the composition of the gut microbiota and promote intestinal carcinogenesis.
By Leigh MacMillan
June 29, 2017

Genetics of lung cancer survival

Vanderbilt investigators have conducted a first-of-its-kind genome-wide association study of lung cancer survival in African-Americans.
By Sanjay Mishra
June 19, 2017

STINGing combination for cancer

A novel immunotherapy combination induced remarkable regression of tumors in a mouse model of head and neck cancer.
By VUMC News and Communications
June 13, 2017

Cancer patient chooses Nashville for VICC care and the Nashville Predators

Los Angeles native Christina Shaw had two powerful goals when she decided to move cross country to live in Nashville – the first was to support her favorite hockey team and the second was to meet a renowned lung cancer specialist at Vanderbilt-Ingram Cancer Center.
By VUMC News and Communications
1 … 40 41 42 43 44 … 72